Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$56.81 – $98.58
20% from low
Exchange
OTC Link
OS
COLOPLAST B ORD
No one on the platform currently holds CLPBF.
No tracked institution reports a position in CLPBF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-19 | $5.0000 | 2026-05-20 |
| 2025-12-08 | $18.0000 | 2025-12-09 |
| 2025-05-09 | $5.0000 | 2025-05-12 |
| 2024-12-09 | $17.0000 | 2024-12-10 |
| 2024-05-13 | $5.0000 | 2024-05-15 |
| 2023-12-08 | $16.0000 | 2023-12-12 |
| Execution date | Ratio |
|---|---|
| 2004-12-16 | 2-for-1 |
No one on the platform has traded CLPBF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $28.9B | +3.6% | $25.09 | $22.92–$29.72 | 2.6× | 11 |
| 2027 | $30.9B | +6.9% | $26.79 | $26.38–$27.26 | 2.4× | 7 |
| 2028 | $32.9B | +6.5% | $28.97 | $28.52–$29.48 | 2.2× | 9 |
| 2029 | $35.2B | +6.8% | $32.63 | $32.12–$33.20 | 2.0× | 9 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-05-12 | $0.91 | $0.95 | +4.3% |
| 2026-02-06 | $0.96 | $0.99 | +3.5% |
| 2025-11-04 | $0.94 | $0.73 | -22.4% |
| 2025-08-19 | $0.83 | $0.61 | -26.8% |
| 2025-05-06 | $0.77 | $0.63 | -18.6% |
| 2025-02-04 | $0.79 | $0.68 | -13.8% |
| 2024-11-05 | $0.86 | $0.82 | -4.9% |
| 2024-08-20 | $0.86 |
| $0.83 |
| -3.9% |
| $20.0B |
| — |
| SBHMYSino Biopharmaceutical Limited | $13.01 | +0.00% | $11.6B | — |
| SDMHFSartorius Stedim Biotech S.A. | $208.48 | +3.67% | $20.3B | — |
Source: Financial Modeling Prep · peers by sector/industry